Yue Zhou
- Cell Biology top 5%
- Oncology top 5%
- HER2/EGFR in Cancer Research 8
- Drug Transport and Resistance Mechanisms 5
- Molecular Biology top 10%
- PI3K/AKT/mTOR signaling in cancer 5
- Natural product bioactivities and synthesis 5
- Immunology top 10%
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy 8
-
- Axon Guidance and Neuronal Signaling 8
-
- Pneumonia and Respiratory Infections 6
-
- Monoclonal and Polyclonal Antibodies Research 5
- Co-authors
- Hiroaki SakuraiParkash S. GillSatoru YokoyamaIkuo SaikiLi YangZhengtao WangKeiichi KoizumiValery Krasnoperov
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Yue Zhou
110 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 113
- Cell Biology 293
- Oncology 471
- Molecular Biology 1.0k
- Immunology 293
- Pharmacology 118
Countries citing papers authored by Yue Zhou
This map shows the geographic impact of Yue Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yue Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yue Zhou more than expected).
Fields of papers citing papers by Yue Zhou
This network shows the impact of papers produced by Yue Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yue Zhou. The network helps show where Yue Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yue Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 5 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 10 | |
| 7 | 2023 | 8 | |
| 8 | 2021 | 9 | |
| 9 | 2021 | 3 | |
| 10 | 2021 | 7 | |
| 11 | 2021 | 1 | |
| 12 | 2020 | 0 | |
| 13 | 2020 | 7 | |
| 14 | 2020 | 11 | |
| 15 | 2019 | 3 | |
| 16 | 2019 | 11 | |
| 17 | 2019 | 5 | |
| 18 | 2013 | 151 | |
| 19 | 2011 | 1 | |
| 20 | 2010 | 33 |
About Yue Zhou
Yue Zhou is a scholar working on Pharmacology, Oncology and Pharmacology, having authored 120 papers that have together received 1.9k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Axon Guidance and Neuronal Signaling (8 papers), HER2/EGFR in Cancer Research (8 papers), Pneumonia and Respiratory Infections (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Drug Transport and Resistance Mechanisms (5 papers), Natural product bioactivities and synthesis (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). The work is most often cited by research in Cell Biology (293 citations), Oncology (471 citations) and Molecular Biology (1.0k citations). Yue Zhou has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Hiroaki Sakurai, Parkash S. Gill, Satoru Yokoyama, Ikuo Saiki, Li Yang, Zhengtao Wang, Keiichi Koizumi, Valery Krasnoperov, Tomohiro Tanaka and Chengzhi Huang. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.